Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.57 -0.04 (-6.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tenaya Therapeutics (TNYA) Change in Receivables (2026)

Updated

Tenaya Therapeutics' Change in Receivables came in at -$10.26 million for Q2 2026.

Analysis

Tenaya Therapeutics (TNYA) Change in Receivables (2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Tenaya Therapeutics reported Change in Receivables of $371,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Tenaya Therapeutics 134.54 Mn 134.54 Mn - -10.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.26 Mn
Mar 31, 2026 10.63 Mn
API Access

Tenaya Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=TNYA&period=max&api_key=YOUR_API_KEY